WeVote
Log In

Bill

Bill

HB 2078

Expanding access to medical cannabis consultants and department of health compliant cannabis product.

2025-2026 Regular Session Introduced by Shelley Kloba and 1 co-sponsor

Expands Washington's medical cannabis access by increasing qualified consultants and requiring Department of Health-compliant products for patient use.

By resolution, reintroduced and retained in present status.
0
WeVote Research Nonpartisan
Bill Summary · HB 2078

Legislative bill overview

HB 2078 expands patient access to medical cannabis by increasing the availability of qualified cannabis consultants and ensuring Department of Health compliance for cannabis products used in medical contexts. The bill appears designed to improve the accessibility and safety standards for patients seeking cannabis as a therapeutic option.

Why is this important

Medical cannabis patients in Washington currently face potential barriers to obtaining knowledgeable guidance and verified products that meet state health standards. This bill directly affects patients with qualifying conditions, healthcare providers advising on cannabis use, and the cannabis retail market's ability to serve medical customers responsibly.

Potential points of contention

  • Consultant qualifications and oversight: Questions about what credentials cannabis consultants must hold, who certifies them, and how they're regulated to ensure competent patient guidance
  • Product testing and compliance costs: Whether stricter Department of Health compliance requirements increase costs for producers and consumers, or create supply chain challenges
  • Integration with traditional healthcare: Potential friction over whether cannabis consultants work alongside licensed physicians or operate independently, and how medical records are shared

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.